Harrow Has Priced An Underwritten Public Offering Of 3.38M Shares At $17.75 Per Share For Aggregate Gross Proceeds Of $60M
Portfolio Pulse from Benzinga Newsdesk
Harrow Health has priced an underwritten public offering of 3.38 million shares at $17.75 per share, aiming to raise aggregate gross proceeds of $60 million.
July 19, 2023 | 11:03 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Harrow Health's public offering of 3.38 million shares at $17.75 per share could dilute existing shareholders' equity, potentially leading to a short-term decrease in stock price.
Public offerings often lead to dilution of existing shareholders' equity, which can result in a short-term decrease in stock price. As the offering is directly related to Harrow Health's stock, the relevance, importance, and confidence are high.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100